Use of Co-trimoxazole in Urinary Tract Infection

  • F. O’Grady
Part of the Handbook of Experimental Pharmacology book series (HEP, volume 64)

Abstract

Infections of the urinary tract are commonly caused by organisms which are sensitive to a large number of antimicrobial agents and the choice of agents for treatment is consequently wide. There is, moreover, ample evidence to show that acute urinary tract infection responds equally well to almost any agent to which the infecting organism is sensitive. Many clinical trials with an assortment of agents show that about 80%–90% of patients respond despite marked differences between the agents in activity, antibacterial range, and pharmacokinetics.

Keywords

Permeability Toxicity Amide Folate Ampicillin 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Amyes SGB, Emmerson AM, Smith JT (1978) R-factor mediated trimethoprim resistance: result of two three-month clinical surveys. J Clin Pathol 31: 850–854PubMedCrossRefGoogle Scholar
  2. Bailey RR, Abbott GD (1978) Treatment of urinary tract infection with a single dose of trimethoprim-sulfamethoxazole. Can Med Assoc J 118: 551–552PubMedGoogle Scholar
  3. Bailey RR, Blake E (1980) Treatment of uncomplicated urinary-tract infections with a single dose of co-trimoxazole. NZ Med J 92: 285–286Google Scholar
  4. Bailey RR, Roberts AP, Gower PE et al. (1971) Prevention of urinary tract infection with low-dose nitrofurantoin. Lancet 2: 1112–1114PubMedCrossRefGoogle Scholar
  5. Brown WL (1929) Discussion on urinary antiseptics. Proc R Soc Med 22: 1127–1150Google Scholar
  6. Brumfitt W, Pursell R (1972) Double blind trial to compare ampicillin, cephalexin, co- trimoxazole and trimethoprim in treatment of urinary infection. Br Med J 2: 673–676PubMedCrossRefGoogle Scholar
  7. Brumfitt W, Faiers MC, Pursell RE et al. (1969) Bacteriological pharmacological and clini-cal studies with trimethoprim-sulphonamide combinations. Postgrad Med J [Suppl] 45: 56–65Google Scholar
  8. Cattell WR, Sardeson JM, Sutcliffe MB, O’Grady F (1968) Kinetics of urinary bacterial response to antibacterial agents. In: O’Grady F, Brumfitt W (eds) Urinary tract infection. Oxford University Press, London, p 212Google Scholar
  9. Cattell WR, Chamberlain DA, Fry JK et al. (1971) Long-term control of bacteriuria with trimethoprim-sulphonamide. Br Med J 1: 377–379PubMedCrossRefGoogle Scholar
  10. Charlton CAC, Crowther A, Davies JG et al. (1976) Three-day and ten-day chemotherapy for urinary tract infections in general practice. Br Med J 1: 124–126PubMedCrossRefGoogle Scholar
  11. Chinn RH, Maskell R, Mead JA, Polak A (1976) Renal stones and urinary infection: A study of antibiotic treatment. Br Med J 2: 1411–1413Google Scholar
  12. Correspondence (1977) Trimethoprim-resistant coliforms. Lancet 2: 774, 926Google Scholar
  13. Datta N, Faiers MC, Reeves DS et al. (1971) R factors in Escherichia coli in faeces after oral chemotherapy in general practice. Lancet 1: 312–315PubMedCrossRefGoogle Scholar
  14. Forbes PA, Drummond KN (1973) Trimethoprim-sulphamethoxazole in recurrent urinary tract infection in children. J Infect Dis [Suppl] 128:S 626—S 628Google Scholar
  15. Gleckman RA (1973) A co-operative controlled study of the use of trimethoprim-sul-phamethoxazole in chronic urinary tract infections. J Infect Dis [Suppl] 128:S 647—S 651Google Scholar
  16. Gleckman R, Crowley M, Natsius GA (1979) Therapy of recurrent invasive urinary-tract infections of men. N Engl J med 301: 878–880PubMedCrossRefGoogle Scholar
  17. Gould JC, Bowie JH, Cameron JDS (1953) Dosage of antibiotics: Relation between the in vitro and in vivo concentrations effective in urinary tract infections. Lancet 1: 361–364Google Scholar
  18. Gower PE, Tasker PRW (1976) Comparative double-blind study of cephalexin and cotrimoxazole in urinary tract infections. Br Med J 1: 684–686PubMedCrossRefGoogle Scholar
  19. Greenwood D (1979) Laboratory methods for the evaluation of synergy. In: Williams JD (ed) Antibiotic interactions. Academic Press, London, p 53Google Scholar
  20. Greenwood D, O’Grady F (1976) Activity and interaction of trimethoprim and sulphamethoxazole against Escherichia coli. J Clin Pathol 28: 162–166CrossRefGoogle Scholar
  21. Greenwood D, Kawada Y, O’Grady F (1980) An in vitro model for assessing optimum antibiotic dosage in urinary tract infection. Infection [Suppl 1] 8:S 35-S 38Google Scholar
  22. Grey D, Hamilton-Miller JMT, Brumfitt W (1979) Incidence and mechanism of resistance to trimethoprim in clinically isolated Gram negative bacteria. Chemotherapy 25: 147–156PubMedCrossRefGoogle Scholar
  23. Grüneberg RN (1975) The use of co-trimoxazole in sulphonamide-resistant Escherichia coli urinary tract infection. J Antimicrob Chemother 1: 305–310PubMedCrossRefGoogle Scholar
  24. Grüneberg RN (1976) Susceptibility of urinary pathogens to various antimicrobial substances: a four year study. J Clin Pathol 29: 292–295PubMedCrossRefGoogle Scholar
  25. Grüneberg RN, Bendall MJ (1979) Hospital outbreak of trimethoprim resistance in pathogenic coliform bacteria. Br Med J 2: 7–9PubMedCrossRefGoogle Scholar
  26. Grüneberg RN, Kolbe R (1969) Trimethoprim in the treatment of urinary infections in hospital. Br Med J 1: 545–547PubMedCrossRefGoogle Scholar
  27. Grüneberg RN, Smellie JM, Leakey A, Atkin WS (1976) Long-term low-dose co-trimoxazole in prophylaxis of childhood urinary tract infection: Bacteriological aspects. Br Med J 2: 206–208Google Scholar
  28. Harbord RB, Grüneberg RN (1981) Treatment of urinary tract infection with a single doseof amoxycillin, co-trimoxazole, or trimethoprim. Brit Med J 283:1301–1302CrossRefGoogle Scholar
  29. Harding GKM, Ronald AR (1974) A controlled study of antimicrobial prophylaxis of re-current urinary infection in women. N Engl J Med 291: 597–601PubMedCrossRefGoogle Scholar
  30. Huovinen P, Tiovanen P (1980) Trimethoprim resistance in Finland after five years of use of plain trimethoprim. Br Med J 1: 72–74CrossRefGoogle Scholar
  31. Jobanputra RS, Datta N (1974) Trimethoprim R factors in enterobacteria from clinical specimens. J Med Microbiol 8: 169–177CrossRefGoogle Scholar
  32. Knothe H (1973) The effect of a combined preparation of trimethoprim and sulphamethoxazole following short-term and long-term administration on the flora of the human gut. Chemotherapy 18: 285–296PubMedCrossRefGoogle Scholar
  33. Koch UJ, Schumann KP, Kuchler R, Kewitz H (1973) Efficacy of trimethoprim, ulphamethoxazole and the combination of both in acute urinary tract infection. Chemotherapy 19: 314–321PubMedCrossRefGoogle Scholar
  34. Kunin CM (1962) Microbial persistence versus reinfection in recurrent urinary tract infections. Antimicrob Agents Chemother 3: 21–25Google Scholar
  35. Maskell R, Okubadejo OA, Payne RH, Pead L (1978) Human infections with thymine-requiring bacteria. J Med Microbiol 11: 33–45PubMedCrossRefGoogle Scholar
  36. Moorhouse EC, Farrell W (1973) Effect of co-trimoxazole on faecal enterobacteria: no emergence of resistant strains. J Med Microbiol 6: 249–252PubMedCrossRefGoogle Scholar
  37. O’Grady F, Chamberlain DA, Stark JE et al. (1969) Long-term, low-dosage, trimethoprimsulphonamide in the control of chronic bacteriuria. Postgrad Med J [Suppl Nov] 45: 61–64Google Scholar
  38. O’Grady F, Fry JK, McSherry A, Cattell WR (1973) Long-term treatment of persistent or recurrent urinary tract infection with trimethoprim-sulfamethoxazole. J Infect Dis [Suppl Nov] 128:S 652-S 656Google Scholar
  39. Pearson NJ, Towner KJ, McSherry AM et al. (1979) Emergence of trimethoprim-resistant enterobacteria in patients receiving long-term co-trimoxazole for the control of intractable urinary-tract infection. Lancet 2: 1205–1208PubMedCrossRefGoogle Scholar
  40. Rapoport J, Rees GA, Willmott NJ et al. (1981) Treatment of acute urinary tract infection with three doses of co-trimoxazole. Brit Med J 283: 1302–1303CrossRefGoogle Scholar
  41. Reeves DS, Faiers MC, Pursell RE, Brumfitt W (1969) Trimethoprim-sulphamethoxazole: comparative study in urinary infection in hospital. Br Med J 1: 541–544PubMedCrossRefGoogle Scholar
  42. Russ GR, Mathew TH, Caon A (1980) Single day or single dose treatment of urinary tract infection with co-trimoxazole. Aust NZ J Med 10: 604–607CrossRefGoogle Scholar
  43. Smellie JM, Grüneberg RN, Leakey A, Atkin WS (1976) Long-term low-dose co-trimoxazole in prophylaxis of childhood urinary tract infection: clinical aspects. Br Med J 2: 203–206PubMedCrossRefGoogle Scholar
  44. Smellie JM, Katz G, Grüneberg RN (1978) Controlled trial of prophylactic treatment in childhood urinary-tract infection. Lancet 2: 175–178PubMedCrossRefGoogle Scholar
  45. Sourander L, Saarimaa H, Arvilommi H (1972) Treatment of sulphonamide-resistant urinary tract infections with a combination of sulphonamide and trimethoprim. Acta Med Scand 191: 1–3PubMedGoogle Scholar
  46. Speller DCE, Bruten DM (1972) Faecal flora after prolonged co-trimoxazole treatment. Br Med J 3: 416PubMedCrossRefGoogle Scholar
  47. Stamey TA (1973) The role of introital enterobacteria in recurrent urinary infections. J Urol 109: 467–472PubMedGoogle Scholar
  48. Stamey TA, Condy M (1975) The diffusion and concentration of trimethoprim in human vaginal fluid. J Infect Dis 131: 261–266PubMedCrossRefGoogle Scholar
  49. Stamey TA, Condy M, Mihara G (1977) Nitrofurantoin and trimethoprim-sulfamethox-azole prophylaxis of urinary tract infection. N Engl J Med 296: 780–783PubMedCrossRefGoogle Scholar
  50. Symposium (1973a) Session V clinical experiences: genitourinary infections. A. Infections of the urinary tract. J Infect Dis [Suppl] 128:S 641—S 665Google Scholar
  51. Symposium (1973b) Septrim symposia. Med J Aust [Suppl June] I: 1–76Google Scholar
  52. Toivanen A, Kasanen A, Sundquist H, Toivanen P (1976) Effect of trimethoprim on the occurrence of drug-resistant coliform bacteria in the faecal flora. Chemotherapy 22: 97–103PubMedCrossRefGoogle Scholar
  53. Towner KJ (1982) Resistance to trimethoprim among urinary tract isolates in the United Kingdom. Rev Infect Dis 4: in the pressGoogle Scholar
  54. Towner KJ, Pearson NJ, Pinn PA, O’Grady F (1980) Increasing importance of plasmid-mediated trimethoprim resistance in enterobacteria: two six-month clinical surveys. Br Med J 280: 517–579PubMedCrossRefGoogle Scholar
  55. Valtonen MV, Valtonen VV, Salo OP, Mäkelä PH (1976) The effect of long-term tetracycline treatment for acne vulgaris on the occurrence of R factors in the intestinal flora of man. Br J Dermatol 95: 311–316PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1983

Authors and Affiliations

  • F. O’Grady

There are no affiliations available

Personalised recommendations